← back to search

Bin Jiang

Tongren Hospital ·
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, and RNA Research and Splicing.
h-index
22
citations
1,623
works
89
NIH funding
primary concept
email

Recent publications

Identification of 3-nitrophenol ester derivatives as novel quorum-sensing inhibitors of Pseudomonas aeruginosa
Journal of Molecular Structure 2022cited by 7position: middledoi
HuR regulates telomerase activity through TERC methylation
Nature Communications 2018cited by 49position: middledoi

Grants

Pacific Northwest Numerical Analysis Seminar 2014, October 18, 2014
NSF1419164$8,0002014–2015PIRePORTER

Frequent collaborators

Huijuan Song · Tongji Hospital1 papers (2022–2022) · 1 papers (2018–2018)Hu Wang · Jinan University1 papers (2018–2018)Wenhao Wu · Jilin University1 papers (2022–2022)Wenbin Ma · Nanjing University of Aeronautics and Astronautics1 papers (2018–2018)Yuyang Tian · Nanchang University1 papers (2018–2018)Xiaotian Zhang · Shanghai University of Traditional Chinese Medicine1 papers (2018–2018)Xiaoyu Qin · Guangzhou University of Chinese Medicine1 papers (2022–2022)Fan Yang · Heilongjiang University of Chinese Medicine1 papers (2018–2018)Hao Tang · Ministry of Education of the People's Republic of China1 papers (2018–2018)Kai Lv · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)Jinbiao Ma · Fudan University1 papers (2018–2018)Yanlian Chen · Sun Yat-sen University1 papers (2018–2018)Apeng Wang · Chinese Academy of Medical Sciences & Peking Union Medical College1 papers (2022–2022)Xiuqin Fan · Shanxi Medical University1 papers (2018–2018)Myriam Gorospe · National Institutes of Health1 papers (2018–2018)Zhou Songyang · Sun Yat-sen University1 papers (2018–2018)Wengong Wang · Peking University1 papers (2018–2018)Xiaolei Cheng · Shenzhen University1 papers (2018–2018)Fengwan Zhang · Nanjing University of Chinese Medicine1 papers (2022–2022)